Delivery Order SPE2DB20D1109-SPE2DB25FN95E
- Not listed
- The Defense Logistics Agency awarded a $33,187.59 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This firm fixed-price contract, awarded on June 25, 2025, with completion scheduled for June 26, 2025, represents a routine pharmaceutical procurement under the agency's medical supply chain operations. The award carries no set-aside designation, indicating competitive procurement from the open market. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $6,601.44 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. The order, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a firm fixed-price delivery under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $5,703.75 delivery order for 60 tablets of Eliquis 5 mg, a widely-used anticoagulant medication. This firm fixed-price delivery order, issued on August 15, 2025, with completion scheduled for August 18, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract was awarded competitively with no...
- The Defense Logistics Agency awarded a $9,078.94 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely-used anticoagulant medication. The contract was awarded on April 24, 2025, with an ultimate completion date of April 25, 2025, and employed firm fixed price pricing with no set-aside designation. Performance of this delivery order is based in Conshohocken, Pennsylvania, the location of AmerisourceBergen Drug Corp's corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a $9,018.03 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The award was made on June 2, 2025, with an ultimate completion date of June 3, 2025, and represents a non-competitive set-aside delivery against an existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a $37,391.10 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. This contract, effective June 2–3, 2025, was competitively awarded without set-aside provisions and carries firm fixed pricing. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $15,614.63 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The contract, executed on August 25, 2025, with completion scheduled for August 26, 2025, operates under firm fixed pricing with no set-aside designation. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $15,808.62 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. The contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025, and carries firm fixed pricing under a non-set-aside competitive award. Performance of the contract is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,065.95 for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This competitive award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, carries a firm fixed price structure with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this delivery order from...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication, with a contract ceiling value of $12,841.34. The award, issued on April 22, 2025, with an ultimate completion date of April 23, 2025, utilizes firm fixed pricing and represents a non-competitive, non-set-aside procurement. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FN95EDelivery Order
The Defense Logistics Agency awarded a $45,549.74 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This non-competitive delivery order, issued on April 24, 2025 with an ultimate completion date of April 25, 2025, represents a routine pharmaceutical procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is classified as a child order under the company's larger prime IDC vehicle, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support mechanism for military healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare programs. As a competitively awarded prime contractor on the DLA Troop Support Medical IDC, the company maintains capability to supply a broad range of pharmaceutical products and medical commodities across multiple therapeutic domains to support military personnel and veterans globally. This delivery order exemplifies the company's role in fulfilling routine pharmaceutical supply needs within the broader context of the DLA's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.5k | 4/24/25 |